Perspectives on anti-CD47 antibody treatment for experimental cancer
- PMID: 23784781
- PMCID: PMC3704033
- DOI: 10.1073/pnas.1308463110
Perspectives on anti-CD47 antibody treatment for experimental cancer
Conflict of interest statement
The author declares no conflict of interest.
Figures
Comment on
-
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response.Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11103-8. doi: 10.1073/pnas.1305569110. Epub 2013 May 20. Proc Natl Acad Sci U S A. 2013. PMID: 23690610 Free PMC article.
References
-
- Kim D, et al. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia. 2012;26(12):2538–2545. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
